Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.

Nature medicine·2025

Same author

Imaging of human stem cell-derived dopamine grafts correlates with behavioural recovery and reveals microstructural brain changes.

Neurobiology of disease·2025

Same author

Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025

Same author

Using gene or cell therapies to treat Huntington's disease.

Handbook of clinical neurology·2024

Same author

Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease.

BMJ open·2024

Search research articles

Related Experiment Video

Updated: May 29, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Cell-based treatments for huntington's disease.

Stephen B Dunnett¹, Anne E Rosser

¹Brain Repair Group, Schools of Biosciences and Medicine, Cardiff University, Cardiff, Wales, UK.

International Review of Neurobiology

|September 13, 2011

Summary

Cell transplantation shows promise for repairing striatal damage in Huntington's disease models. Clinical trials show encouraging results, but further strategies are needed to match animal model recovery and improve patient outcomes.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Published on: January 8, 2022

Related Experiment Videos

Last Updated: May 29, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Published on: January 8, 2022

Area of Science:

Neuroscience
Regenerative Medicine
Cell Therapy

Background:

Striatal cell transplantation in animal models effectively repairs damage and improves function.
This approach has been translated to human clinical trials for Huntington's disease, a progressive neurodegenerative disorder.

Purpose of the Study:

To evaluate the efficacy of embryonic striatal cell transplantation for repairing striatal damage.
To identify strategies for improving clinical outcomes in Huntington's disease patients.

Main Methods:

Transplantation of embryonic striatal cells into the striatum of experimental animals (rats, mice, monkeys).
Clinical application of cell transplantation in a limited number of Huntington's disease patients.

Main Results:

Animal models demonstrated significant repair and functional recovery across motor, cognitive, and learning domains.
Preliminary clinical data in Huntington's disease patients showed encouraging results, but were less consistent than in animal models.

Conclusions:

Embryonic striatal cell transplantation is a viable strategy for striatal repair, showing significant potential in preclinical studies.
Clinical translation requires further optimization, including complication management, standardization, patient selection, and alternative cell sources, to achieve robust outcomes comparable to animal models.